Understanding comorbid conditions with type 2 diabetes mellitus (T2DM) is critical for clinical decision-making regarding the choice of pharmacotherapy.

This study aimed at describing the prevalence and co-prevalence of comorbidities, including chronic kidney disease (CKD) and cardiovascular disease (coronary artery disease (CAD), cerebrovascular disease, peripheral arterial disease (PAD) and congestive heart failure (CHF)), among patients with T2DM.

The most prevalent comorbidities were CKD (44.3%), mostly stages 2 and 3, and  CAD (15%). The prevalence of CHF (0.7%), PAD (2.3%) and cerebrovascular diseases (1.3%) was low.

Clinicians need to proactively screen for the presence of comorbid conditions with T2DM, especially CKD and CAD. The CHF co-prevalence may be underestimated and underdiagnosed, being a relatively newly focused emerging comorbidity.